IR CANCELLED; US REGISTRATION CANCELLED
on 21 Jul 2023
Last Applicant/ Owned by
F-69001 Lyon
FR
Serial Number
79136119 filed on 22nd Jul 2013
Registration Number
4599332 registered on 09th Sep 2014
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
FABENFLU
Pharmaceuticals, namely, immunotherapeutic products; veterinary products, namely, immunotherapeutic products; pharmaceuticals for immunotherapy; antibodies for pharmaceutical and veterinary use, in the field of immunotherapy; medicines for human medicine or veterinary use, namely, immunotherapeutic products; sanitary products for medical purposes; vaccines; sera for immunotherapeutic purpose; para Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, immunotherapeutic products; veterinary products, namely, immunotherapeutic products; pharmaceuticals for immunotherapy; antibodies for pharmaceutical and veterinary use, in the field of immunotherapy; medicines for human medicine or veterinary use, namely, immunotherapeutic products; sanitary products for medical purposes; vaccines; sera for immunotherapeutic purpose; parasiticides; medical plasters and medical dressings; medicated baths preparations
Mark Details
Serial Number
No 79136119
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84188.0002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Feb 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| 17th Feb 2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| 27th Jun 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 12th Apr 2022 | INVALIDATION PROCESSED |
| 12th Apr 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 26th Nov 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 26th Mar 2021 | CANCELLED SECTION 71 |
| 09th Sep 2019 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 07th Jul 2017 | NEW REPRESENTATIVE AT IB RECEIVED |
| 27th Mar 2015 | FINAL DECISION TRANSACTION PROCESSED BY IB |